<DOC>
	<DOC>NCT02301208</DOC>
	<brief_summary>This is a randomized Phase III study to evaluate efficancy of weekly cisplatin or nedaplatin concurrent with Intensity-modulated radiation therapy in Nasopharyngeal Carcinoma (NPC).</brief_summary>
	<brief_title>Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Pathologically confirmed untreated NPC patients T12N13M0 or T34NxM0 1870 years old with MRI examinations ECOG â‰¤ 2 With written consent With a second cancer Pregnancy With other severe diseases (blood,liver ,kidney or heart diseases) Could not be staged properly Without written consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>